Concepedia

Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial

Jean‐Christophe Corvol, Franck Durif, Wassilios G. Meissner, Jean-Philippe Azulay, Raphaël Haddad, Raquel Guimarães‐Costa, Louise‐Laure Mariani, Florence Cormier‐Dequaire, Claire Thalamas, Monique Galitzky,

Parkinsonism & Related Disorders · 2018 · 18 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Andrew Hughes, S. E. Daniel, Linda Kilford et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 10.4K citations · Full text

, , +15

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman et al. · Movement Disorders · 2008 · 7.5K citations · Full text

, , +16

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Leonard Verhagen Metman, Paolo Del Dotto, Pepijn van den Munckhof et al. · Neurology · 1998 · 516 citations

, , +17

A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

Robert A. Hauser, Jeffrey Friedlander, Theresa Zesiewicz et al. · Clinical Neuropharmacology · 2000 · 298 citations

, , +14

How to Examine Patients Using the Abnormal Involuntary Movement Scale

Mark R. Munetz, Sheldon Benjamin · Psychiatric Services · 1988 · 264 citations

, , +16